Group 1 - The core point of the article is that Tianen Kang (301263) announced that its wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd., has received a drug registration certificate for Methimazole tablets from the National Medical Products Administration [1] Group 2 - The drug registration certificate signifies regulatory approval for the production and sale of Methimazole tablets, which may enhance the company's product portfolio and market presence [1] - This development could potentially lead to increased revenue streams for the company as it expands its offerings in the pharmaceutical sector [1] - The approval reflects the company's commitment to compliance with national regulations and its capability in the biotechnology field [1]
泰恩康：全资子公司收到甲巯咪唑片药品注册证书